Feed / RVTY

Revvity, Inc.

RVTY

Healthcare · 112.50 -0.9% today

Jodie read · what matters now

Revenue increased 7.0% versus the comparable filing period.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to RVTY, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections13 verified links11 additional receipts in Pro
Organic co-movement groupHealthcare Diagnostics · ParticipantDiscovered from trading behaviour, not sector labels · Open group →

Latest filing assessment · baseline

The latest filing presents a mixed picture

10-Q filed 2026-05-12 against the comparable filing from 2025-05-06.

mixed
OperationsmixedEvidence score +1
liquidityneutralEvidence score 0
valuationmixed

What improved

  • Revenue increased 7.0% versus the comparable filing period.

What weakened

  • Net margin fell 0.6 percentage points.

Filing receipts

As a percentage of revenue, cost of revenue increased to 45.5% for the three months ended April 5, 2026, from 43.5% for the three months ended March 30, 2025, resulting in a decrease in gross margin of 200 basis points to 54.5% for the three months ended April 5, 2026, from 56.5% for the three months ended March 30, 2025, primarily due to product mix shift, changes in foreign exchange rates, increased tariffs and impact of the extra fiscal week.

Interest and Other Expense, Net Interest and other expense, net, consisted of the following: Three Months Ended April 5, 2026 March 30, 2025 (In thousands) Interest income $ (6,304) $ (10,081) Interest expense 24,718 22,964 Change in fair value of investments 4,204 (3,073) Other components of net periodic pension (credit) cost (251) 6,787 Foreign exchange losses and other expense, net 3,527 3,251 Total interest and other expense, net $ 25,894 $ 19,848 The decrease in interest income for the three months ended April 5, 2026 as compared to the three months ended March 30, 2025 was primarily due to a decrease in marketable securities and short-term investments.

Our consolidated gross margins decreased 200 basis points from 56.5% to 54.5% in the first quarter of fiscal year 2026, as compared to the first quarter of fiscal year 2025, primarily due to product mix shift, changes in foreign exchange rates, increased tariffs and impact of the extra fiscal week.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Who this business touches

The relationships behind RVTY

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MSFTMicrosoft CorporationpartnerFull receipt with Pro →

Depended on by

COOThe Cooper Companies, Inc.competitorFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 11 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

RVTY is currently a Participant in the organic co-movement group Healthcare Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.